August 27, 2012 15:52 ET Pristine Solutions, Inc. (OTCQB: PRTN) End of Day Volume Leader

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO NewsWire

NEW YORK, NY--(Marketwire - Aug 27, 2012) - offers free real-time market quotes and level II access along with breaking news from leading North American stock exchanges. MNS Quotes' pre-market alert provides a heads up on top gaining and most alerted small cap stocks from the OTC and Pink Sheet markets. We are currently tracking PRTN. This is very strong volume trader with plenty of momentum. We recommend tracking it on your portfolio in real-time for free at

Pristine Solutions, Inc. (OTCQB: PRTN) announced today it completed the acquisition of Eaton Scientific, which has identified, developed, and filed a patent for a novel indication of an existing FDA approved drug, homatropine, for the non-hormonal treatment of hot flashes in pre-menopausal, pari-menopausal, and post-menopausal women.

PRTN had traded over 97 million shares in on the day up at $0.387 at last check. We look for a 100 million share day by close. This is a heavy volume trader.

For more on what's moving in the markets and free real-time / level 2 market quotes see

Other active stocks are The Fight Zone, Inc. (PINKSHEETS: TFZI), Firemans Contractors, Inc. (OTCQB: FRCN) and Active Health Foods, Inc. (OTCQB: AHFD).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO Circuit twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact Information